A functional role for Nlrp6 in intestinal inflammation and tumorigenesis

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7187-7194

  Chen, Grace Y ^a,b   Liu, Maochang ^a,b   Wang, Fuyuan ^a,b   Bertin, John ^c   Núñez, Gabriel ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 18; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PROTEIN NLRP6; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; COLITIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; HEMATOPOIETIC CELL; HOMEOSTASIS; INTESTINE EPITHELIUM; INTESTINE INJURY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN ANALYSIS; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR IMMUNITY; WILD TYPE;

ANIMALS; COLITIS; COLONIC DISEASES; HOMEOSTASIS; INFLAMMATION; INTESTINAL DISEASES; INTESTINES; MICE; MICE, KNOCKOUT; NEOPLASMS; RECEPTORS, CELL SURFACE;

EID: 79959540809     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100412     Document Type: Article

References (37)

1. Chen, G., M. H. Shaw, Y. G. Kim, and G. Nuñez. 2009. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 4: 365-398.
2. Watanabe, T., N. Asano, P. J. Murray, K. Ozato, P. Tailor, I. J. Fuss, A. Kitani, and W. Strober. 2008. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis. J. Clin. Invest. 118: 545-559.
3. Bouskra, D., C. Brézillon, M. Bérard, C. Werts, R. Varona, I. G. Boneca, and G. Eberl. 2008. Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 456: 507-510. (Pubitemid 352759006)
4. Zaki, M. H., K. L. Boyd, P. Vogel, M. B. Kastan, M. Lamkanfi, and T. D. Kanneganti. 2010. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32: 379-391.
5. Chen, G. Y., M. H. Shaw, G. Redondo, and G. Núñez. 2008. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 68: 10060-10067.
6. Davis, B. K., H. Wen, and J. P. Ting. 2011. The Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases. Annu. Rev. Immunol. 29: 707-735.
7. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 10: 417-426. (Pubitemid 35007355)
8. Boyden, E. D., and W. F. Dietrich. 2006. Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38: 240-244.
9. Kumar, H., S. Pandey, J. Zou, Y. Kumagai, K. Takahashi, S. Akira, and T. Kawai. 2011. NLRC5 deficiency does not influence cytokine induction by virus and bacteria infections. J. Immunol. 186: 994-1000.
10. Davis, B. K., R. A. Roberts, M. T. Huang, S. B. Willingham, B. J. Conti, W. J. Brickey, B. R. Barker, M. Kwan, D. J. Taxman, M. A. Accavitti-Loper, et al. 2011. Cutting edge: NLRC5-dependent activation of the inflammasome. J. Immunol. 186: 1333-1337.
11. Grenier, J. M., L. Wang, G. A. Manji, W. J. Huang, A. Al-Garawi, R. Kelly, A. Carlson, S. Merriam, J. M. Lora, M. Briskin, et al. 2002. Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-kappaB and caspase-1. FEBS Lett. 530: 73-78. (Pubitemid 35248189)
12. Allen, I. C., E. M. TeKippe, R. M. Woodford, J. M. Uronis, E. K. Holl, A. B. Rogers, H. H. Herfarth, C. Jobin, and J. P. Ting. 2010. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207: 1045-1056.
13. Zaki, M. H., P. Vogel, M. Body-Malapel, M. Lamkanfi, and T. D. Kanneganti. 2010. IL-18 production downstream of the Nlrp3 inflammasome confers protection against colorectal tumor formation. J. Immunol. 185: 4912-4920.
14. Dupaul-Chicoine, J., G. Yeretssian, K. Doiron, K. S. Bergstrom, C. R. McIntire, P. M. LeBlanc, C. Meunier, C. Turbide, P. Gros, N. Beauchemin, et al. 2010. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32: 367-378.
15. Dinarello, C. A. 1999. Interleukin-18. Methods 19: 121-132. (Pubitemid 29497762)
16. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378: 88-91.
17. Takeda, K., H. Tsutsui, T. Yoshimoto, O. Adachi, N. Yoshida, T. Kishimoto, H. Okamura, K. Nakanishi, and S. Akira. 1998. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 8: 383-390. (Pubitemid 28188898)
18. Coussens, L. M., and Z. Werb. 2002. Inflammation and cancer. Nature 420: 860-867. (Pubitemid 36019639)
19. Mantovani, A. 2010. Molecular pathways linking inflammation and cancer. Curr. Mol. Med. 10: 369-373.
20. Popivanova, B. K., K. Kitamura, Y. Wu, T. Kondo, T. Kagaya, S. Kaneko, M. Oshima, C. Fujii, and N. Mukaida. 2008. Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest. 118: 560-570.
21. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G. Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
22. Allavena, P., G. Germano, F. Marchesi, and A. Mantovani. 2011. Chemokines in cancer related inflammation. Exp. Cell Res. 317: 664-673.
23. Kollmar, O., C. Scheuer, M. D. Menger, and M. K. Schilling. 2006. Macrophage inflammatory protein-2 promotes angiogenesis, cell migration, and tumor growth in hepatic metastasis. Ann. Surg. Oncol. 13: 263-275.
24. Lukas, M. 2010. Inflammatory bowel disease as a risk factor for colorectal cancer. Dig. Dis. 28: 619-624.
25. Hu, B., E. Elinav, S. Huber, C. J. Booth, T. Strowig, C. Jin, S. C. Eisenbarth, and R. A. Flavell. 2010. Inflammation-induced tumorigenesis in the colon is regulated by caspase-1 and NLRC4. Proc. Natl. Acad. Sci. USA 107: 21635-21640.
26. Salcedo, R., A. Worschech, M. Cardone, Y. Jones, Z. Gyulai, R. M. Dai, E. Wang, W. Ma, D. Haines, C. O'hUigin, et al. 2010. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 207: 1625-1636.
27. Ishikura, T., T. Kanai, K. Uraushihara, R. Iiyama, S. Makita, T. Totsuka, M. Yamazaki, T. Sawada, T. Nakamura, T. Miyata, et al. 2003. Interleukin-18 overproduction exacerbates the development of colitis with markedly infiltrated macrophages in interleukin-18 transgenic mice. J. Gastroenterol. Hepatol. 18: 960-969.
28. Siegmund, B. 2010. Interleukin-18 in intestinal inflammation: friend and foe? Immunity 32: 300-302.
29. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241. (Pubitemid 38962578)
30. Pull, S. L., J. M. Doherty, J. C. Mills, J. I. Gordon, and T. S. Stappenbeck. 2005. Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc. Natl. Acad. Sci. USA 102: 99-104.
31. Brown, S. L., T. E. Riehl, M. R. Walker, M. J. Geske, J. M. Doherty, W. F. Stenson, and T. S. Stappenbeck. 2007. Myd88-dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J. Clin. Invest. 117: 258-269.
32. Dunn, G. P., H. Ikeda, A. T. Bruce, C. Koebel, R. Uppaluri, J. Bui, R. Chan, M. Diamond, J. M. White, K. C. Sheehan, and R. D. Schreiber. 2005. Interferon-gamma and cancer immunoediting. Immunol. Res. 32: 231-245.
33. Shresta, S., C. T. Pham, D. A. Thomas, T. A. Graubert, and T. J. Ley. 1998. How do cytotoxic lymphocytes kill their targets? Curr. Opin. Immunol. 10: 581-587.
34. Fantuzzi, G., G. Ku, M. W. Harding, D. J. Livingston, J. D. Sipe, K. Kuida, R. A. Flavell, and C. A. Dinarello. 1997. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J. Immunol. 158: 1818-1824.
35. van de Veerdonk, F. L., M. G. Netea, C. A. Dinarello, and L. A. Joosten. 2011. Inflammasome activation and IL-1b and IL-18 processing during infection. Trends Immunol. 32: 110-116.
36. Greten, F. R., L. Eckmann, T. F. Greten, J. M. Park, Z. W. Li, L. J. Egan, M. F. Kagnoff, and M. Karin. 2004. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296. (Pubitemid 39061110)
37. Mariathasan, S., D. S. Weiss, K. Newton, J. McBride, K. O'Rourke, M. Roose-Girma, W. P. Lee, Y. Weinrauch, D. M. Monack, and V. M. Dixit. 2006. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232.